Furthermore, NDUFA12 has emerged as a target protein for the natural small molecule Ertredin, which has demonstrated efficacy in inhibiting the growth of cancer cells harboring EGFRvIII mutations, associated with anti-tumor activity (Park et al. 2024). This evidence concerns the gene NDUFA12 and cancer.